Eris Lifesciences Receives ANVISA approval for Sterile Injectable Facility
Mumbai, Aug 26,: Following the Anvisa approval of an oral dose manufacturing unit, Eris Lifesciences Limited, a leading Indian branded formulations company, today announced that one of its sterile injectable manufacturing facilities in Ahmedabad has received approval from Anvisa, Brazil’s national health regulatory agency. This facility is part of subsidiary Swiss Parenterals that was acquired…
